TuHURA Biosciences, Inc./NV — Form 8-K
Filed October 16, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 22/100
What the filing says
Form 8-K filed 2026-10-16 reports Item 2.03 (creation of direct financial obligation or off-balance sheet arrangement) and Item 9.01 (financial statements/exhibits), but the filing stub does not disclose the counterparty, dollar amount, terms, or nature of the obligation. Full document details are unavailable in this EDGAR index view.
Why this rating
Cannot assess materiality without disclosed amounts/terms. If obligation is material relative to $111M market cap, significance could rise sharply upon review of full filing text.
Extracted items
- 2.03 material obligation
- 9.01 exhibits
See more from October 16, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.